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A 2 months old female Vietnamese potbellied pig presented to a veterinary teaching
hospital with a referring complaint of pruritus. A human caretaker of the pig had recently
been diagnosed with a Sarcoptes spp. dermatitis. Microscopic examination of the skin
scrape samples and BLAST analysis confirmed the species of the mite as most closely
related to Sarcoptes scabiei var. canis (AY493391). The pig was treated with afoxolaner
as previous treatment with ivermectin was not efficacious. Recheck examinations and
follow up revealed the pig to be non-pruritic and resolving. Afoxolaner may be a
therapeutic option when treating Sarcoptes spp. infections in companion pigs.
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INTRODUCTION
Isoxazolines are a veterinary drug class that have recently become available for the prevention of
ectoparasites of cats and dogs. Available via oral and dermal application, with both forms leading
to systemic distribution, they maintain long periods of activity after a single dose (1). These drugs
bind gamma-aminobutyric acid gated chloride receptors as well as l-glutamate chloride channels.
This receptor binding then results in the death of the parasite (2). The isoxazolines selectively target
arthropod receptors over mammalian receptors and as such have been used for both experimental
and naturally occurring flea, tick, and mite infections in dogs and cats (2–5).
Sarcoptic mange is an occasional infection in commercial pigs, and outside of a few case
reports is not well-described in companion miniature pigs, such as Vietnamese potbellied pigs.
When sarcoptic mange is encountered in pigs, risks include zoonotic transmission to humans in
close contact (6). Previously reported treatments comprise injectable ivermectin combined with
chlorhexidine shampoo (6). Currently no case reports describe the use of an isoxazoline drug, such
as afoxolaner for the treatment of sarcoptic mange in a companion miniature pig.
Companion miniature pigs are increasing in popularity as pets in North America, with some
estimates suggesting the total population being in the hundreds of thousands (7). Although all
swine are considered food animals in the United States, many owners of potbellied pigs consider
them companion animals. This presents a challenge to veterinarians, when making treatment
decisions involving extralabel drug use. With their demonstrated efficacy in small animals, the
isoxazoline class of drugs presents a potential option for the treatment of external parasites
in miniature companion pigs. In this report, we demonstrate the usefulness of a commercial
formulation of afoxolaner for the treatment of Sarcoptes scabiei var. canis in a juvenile potbelly pig.
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FIGURE 1 | Photographs of the pig taken on initial examination. Note the
bilateral excoriations. (A) Right Lateral View. (B) Left Lateral View.
Case Presentation and History
A 2-months-old, 4.3 kg, intact female Vietnamese potbellied pig
presented to Iowa State University Food Animal and Camelid
Hospital to evaluate pruritus of 2 weeks duration. The owner
had noticed pruritus and alopecia, and had administered one
dose of ivermectin (0.6 mg/kg, PO). The client noticed no change
in clinical condition following treatment. Shortly after the pig
was noted to be pruritic, a resident of the home, who had
close contact with the pig, developed skin lesions and pruritus,
which was diagnosed by the resident’s primary care physician as
suspect scabies. The pig was examined by a board-certified-large
animal internal medicine specialist as well as a board-certified
veterinary dermatologist. Parasites obtained from skin scrapings
were evaluated by a board-certified parasitologist, and additional
material was retained for molecular characterization.
MATERIALS AND METHODS
Molecular Characterization
For genetic confirmation of mite identity, a portion of the
mitochondrial cytochrome C oxidase subunit 1 (Cox 1) was
amplified (8). DNA was extracted from mites present in
the skin scraping using the DNeasy blood and tissue kit
(Qiagen, Valencia, CA), using the manufacturer’s protocol.
Mt-Cox1 gene was amplified in 50 µL reactions with 2 µL
of extracted DNA, 3mM of MgCl2, 200µM of dNTPs, 1x
PCR buffer, and 2 units of Taq DNA polymerase (GoTaq Flexi,
Promega, Madison, WI), and 2.5µM of primers ScabCox1F
5’- GACACCCAGAAGTTTACATTC-3’ and ScabCox1R 5’- T
ATATTTTGATAATGAATCTC-3’ (9). PCR conditions were
94◦C for 2min, 30 cycles of 94◦C for 30 s, 45◦C for 15 s, 72◦C
for 1min, and 72◦C for 5min. PCR amplification was confirmed
by gel electrophoresis in 0.8% agarose gels. Amplification
products were purified using the PureLink PCR purification
kit (ThermoFisher, Waltham, MA, USA), and sequenced on
an Applied Biosystems 3730 × l DNA analyzer. Contigs were
assembled using CAP3 (10). Nucleotide BLAST analysis was
carried out on GenBank, and 34 mt-Cox I gene sequences of
S. scabiei and one of Amblyomma americanum were retrieved
from the GenBank nucleotide database. Multiple sequence
alignments were created using Clustal omega (11). The best
phylogenetic model was selected using SMS (12) and maximum
FIGURE 2 | Mite identified from skin scraping (magnification: 20X). Note the
long unjointed pedicles, cuticular spines, setae, and terminal anus consistent
with Sarcoptes spp.
likelihood phylogenetic analysis using the Hasegawa-Kishino-
Yano model with invariable sites (HKY85+I) was conducted in
Mega X (13). Haplotype analysis was carried out using DnaSP
6 (14). One hundred and two total S. scabiei cox I sequences
obtained from GenBank and the present study were analyzed at
385 sites. Fourty-four unique haplotypes were identified. The cox
I sequence from the present study belongs to a novel haplotype.
RESULTS
Physical Examination
Dermatological examination on the initial visit revealed the
patient had moderate diffuse generalized erythema and with
generalized hypotrichosis. Mild diffuse generalized crusting with
scattered papules along the dorsal and ventral trunk were also
present. More focally moderate crusting was appreciated along
the pinnal margins and the cranial dorsum. Moderate to marked
diffuse scale was more prominent along the dorsal surfaces. Mild
excoriations were present over the right and left lateral thorax and
caudal aspects of the forelimbs, bilaterally (Figure 1). Minimal
manipulation of the patient’s dorsum or head was noted to elicit
severe pruritic activity. The remainder of physical examination
findings were within normal limits.
Parasite Morphology
Skin scrapings revealed sarcoptiform astigmatid mites bearing
long unjointed pedicles, cuticular spines, setae, and a terminal
anus (Figure 2). Taken together, the morphological features of
the mites were consistent with Sarcoptes spp.
Molecular Identification
A partial amplicon of the mitochondrial cytochrome c oxidase
subunit I gene was amplified by PCR from mite DNA and
sequenced (GenBank: MN985652.1). Nucleotide BLAST analysis
of the 722 bp product revealed that the pig isolate in the
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TABLE 1 | Nucleotide BLAST results of the partial mitochondrial cytochrome c
oxidase subunit I product from this study.
GenBank Parasite Variant/Host Partial mt-Cox
Accession I sequence
number identity
AY493391 Sarcoptes scabiei var. canis 99.72%
MF083742 Sarcoptes scabiei Host: Koala
Phascolarctos cinereus
99.58%
MF083738 Sarcoptes scabiei var. wombati 99.58%
MF083734 Sarcoptes scabiei Host: Koala
Phascolarctos cinereus
99.58%
LN874268 Sarcoptes scabiei var. hominis 99.58%
AY493395 Sarcoptes scabiei var. canis 99.58%
AY493382 Sarcoptes scabiei var. hominis 99.58%
AY493392 Sarcoptes scabiei var. canis 99.45%
AY493383 Sarcoptes scabiei var. hominis 99.45%
MF083741 Sarcoptes scabiei var. wombati 99.31%
MF083740 Sarcoptes scabiei var. wombati 99.31%
MF083736 Sarcoptes scabiei var. wombati 99.31%
MF083735 Sarcoptes scabiei var. wombati 99.31%
AY493396 Sarcoptes scabiei Host: Chimpanzee Pan
troglodytes
99.31%
MF083739 Sarcoptes scabiei var. wombati 99.17%
LN874270 Sarcoptes scabiei var. suis 99.17%
present study had the highest identity with S. scabiei var. canis
(AY493391). BLAST results are listed in Table 1. Phylogenetic
analysis showed that the pig isolate was in the same cluster as
sequences from Sarcoptes scabiei isolated from dogs, koalas, and
wombats. Figure 3 represents a maximum likelihood analysis of
the genotype from this study.
Treatment
Due to the treatment failure of the previously administered
ivermectin, an ∼2.6 mg/kg dose of afoxolaner was administered
orally, with instructions to repeat in 1 month. The pig was closely
monitored for 72 h after administration and no adverse effects
were noted. The clients were instructed to thoroughly clean the
pig’s bedding and limit contact with other pigs and people in the
household until after resolution of pruritus.
Follow-Up Examination
Three weeks after the initial examination the pig was
re-evaluated. Physical examination findings were within normal
limits and a dermatologic examination revealed widespread
crusting along the dorsum, no active pruritis or superficial
inflammation was noted (Figure 4). The owner reported that
pruritic behavior had ceased ∼4 days after administration of
afoxolaner. Microscopic examination of the skin revealed no live
mites, or eggs. Follow up communication 8 and 16 weeks after
examination revealed resolved alopecic areas and no pruritus
observed since the original episode.
DISCUSSION
Sarcoptes infections cause sarcoptic mange in domestic and wild
mammals. The genus Sarcoptes is thought to contain a single
species, S. scabiei, with host-adapted variants. In pigs, sarcoptic
mange can occur as an acute cause of pruritis in fattening pigs,
and a chronic herd problem in adults, which can be difficult to
eliminate from a herd (15). Because multiple treatments are often
required to clear infections, sarcoptic mange cases can appear
clinically resistant to avermectins (16, 17). While not commonly
reported in miniature companion pigs, zoonotic transmission is
possible (6). There are significant gaps in understanding host
specificity in Sarcoptes scabiei. It is of note that in the present
study, mites isolated from pigs were closely related to isolates
from dogs and Australian marsupials. There have been reports
of S. suis infections (9), but not S. canis in pigs as of this
case report. While injectable ivermectin, dosed at 0.3 mg/kg
for two subcutaneous injections (q 14 d) has been effective
when combined with chlorhexidine baths in potbellied pigs (6),
a relative paucity of information exists for the efficacy of this
drug when administered orally to miniature pigs. In this case,
the patient presented to a university hospital with an infection
suspected to be resistant due to past treatment failure.
In production pigs oral ivermectin administration has been
demonstrated to aid in controlling mange (18). At this time it
is unknown why the previous oral administration of ivermectin
was not clinically efficacious in this patient, and as the bottle
was not located it is possible that this product was expired or
otherwise not administered appropriately by the client. As the
drug administration was not witnessed, it is possible that the pig
expelled the ivermectin shortly after administration. Resistance
to therapy, as postulated as emerging in human scabies infections
(19), could also be a potential reason for treatment failure in this
case. However, this cannot be absolutely confirmed by this case,
as the only observation was a lack of efficacy.
Afoxolaner is an isoxazoline that blocks native and expressed
arthropod GABA-gated chloride channels, including wild-type
and channels possessing the resistance to dieldrin (A302S)
mutation (20). In dogs and cats it has demonstrated considerable
efficacy for ectoparasite control for fleas (2, 21), ticks (21), and
mites including Sarcoptes (5), Otodectes (3), and Demodex (22,
23).With the selectivity for invertebrate channels the isoxazolines
are thought have a wide margin of safety in mammals. While
commonly used in dogs with rarely reported adverse effects,
there have been reports of neurological toxicity (i.e., seizures)
associated with this class of antiparasitics (24). Our case, and a
research project using isoxazolines in pigs as a model for human
disease (25) observed no neurological effects, suggesting that
these drugs may be safe for use in pigs.
Cox I amplified from the porcine isolate in the present
study had the highest identity with S. scabiei var. canis
isolated from the USA, but was not 100% identical. While
microsatellite genotyping demonstrates geographical separation
between isolates and biological adaptation to the herbivore-,
omnivore-, and carnivore- host groups (26), Cox I haplotype
variation does not completely correlate with established
host variants. Additionally, association between host and
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FIGURE 3 | Maximum likelihood phylogenetic analysis of 36 partial mt-cox1 sequences analyzing 682 basepairs in each sequence using the HKY85+I method. The
percentage of trees in which the associated taxa clustered together is shown next to the branches. The sequence from the present study is indicated (·). Sequences
obtained from GenBank records are indicated by accession numbers.
named variants are not absolute due to cross host species
transfer due to host interactions (27). Further research is
needed to determine the affinity of S. scabiei var. canis for
porcine infestations.
At this time the authors were unable to identify other
naturally-occurring cases of S. scabiei var. canis infections
in pigs. Experimental transmission has been documented
previously (28), however that study utilized microscopy, instead
of sequencing for mite identification. Traditionally, causes of
sarcoptic mange in pigs are described as caused by S. scabiei
var. suis (15, 18). The mitochondrial subunit 1 cytochrome c
oxidase (COX-1) marker is an informative genetic marker for
characterization of S. scabiei (29). Analysis of COX-1 markers
from our case identified a 99.72% sequence identity with
S. scabiei var. canis AY493391. It has been suggested that the
host preference is partially correlated with genetic differences
within S. scabiei sequences (9), however it is uncertain at
this time where the source of infestation was for our case.
Regardless, S. scabiei var. canis infestation has been described
in immunocompromised human patients (30), so clinicians
and clients should be aware of the zoonotic implications of
infestations of the mite in pigs.
Companionminiature pigs would be considered a food animal
in the United States from a regulatory perspective (7, 31).
Although uncommon, there are instances where companion pigs
have entered the food chain (32). As such, clinicians should be
aware of the regulatory requirements involving extra-label drug
use in these species. The use of afoxolaner in this case was justified
by the veterinary care team as treatment failure with ivermectin
was suspected, and there was a need for a rapid resolution due
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FIGURE 4 | Photographs from recheck examination. Note the hair regrowth,
increased dorsal scaling and resolution of the previously examined
excoriations.
to the human case observed by the owner. Additionally, while
ivermectin is labeled for the treatment of S. scabiei var. suis
infestations in pigs, there are regional differences in available
formulations, and afoxolaner has demonstrated efficacy for
treatment of this mite in naturally infested dogs (5). While no
withdraw information exists for afoxolaner, a similar compound,
fluralaner is currently labeled in Europe for use in poultry for the
treatment of red mite (Dermanyssus gallinae) with a 14 days meat
withdrawal and 0 day egg withdrawal period.
This report details the use of afoxolaner for the treatment
of Sarcoptes in a companion miniature pig presented to a
veterinary teaching hospital for pruritus caused by suspected
infestation with Sarcoptes scabiei var. canis. Due to prior
unsuccessful treatment with ivermectin the pig was administered
afoxolaner and had resolution of pruritus within 96 h of
administration. No adverse effects were noted in the patient after
administration of the drug. Afoxolaner and other isoxazolines
may prove to be effective therapies for miniature companion pigs
with ectoparasites.
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